Red Star Capital Bureau reported on February 21 that according to Credit China, Ali Health Pharmacy Pharmaceutical Chain *** hereinafter referred to as "Ali Health Pharmacy") recently added an administrative penalty and was fined 450,000 yuan for violating the Advertising Law for the product advertising content it published.
Screenshot from Credit China.
According to the punishment content, from November 17, 2021 to September 12, 2023, according to the report clues, the product advertising content released by Ali Health Pharmacy violated the "Advertising Law of the People's Republic of China" and was placed on file for investigation.
It has been found that the advertisements for health foods, drugs and medical devices such as "** Partner Mengzhi Tiger Calcium, Iron and Zinc Oral Liquid" released by Ali Health Pharmacy on the Tmall platform "Ali Health Pharmacy" have not been reviewed by the advertising agency; The advertisements for common foods such as "Wanglaoji Collagen Snow Lotus Drink" have deceived and misled consumers with false or misleading content; The advertisements for common foods such as "Beijing Tong Ren Tang Oyster Tablets and Tablet Candy" and "Baiyun Mountain Eye Care Liquid" (daily necessities) are related to the function of diseases; The advertisement of the prescription drug "Changyao Folic Acid Tablets (Guoyao Zhun Zi H32023302)" released is published in a medical and pharmaceutical professional journal jointly designated by the non-*** health administrative department and the *** drug regulatory department.
In the end, Ali Health Pharmacy was fined 450,000 yuan, and at the same time ordered to stop publishing the advertisements involved in the case, ordered to eliminate the impact within the corresponding scope, and the punishment authority was the Market Supervision and Administration Bureau of Huangpu District, Guangzhou.
Red Star News reporter Deng Lingyao.
Edited by Xiao Ziqi.
*Red Star News, Newspaper Rewards! ）